MedTrace Logo

Homocysteine in Critically Ill Preeclampsia

NCT06413576 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2026-04-07

No results posted yet for this study

Summary

Preeclampsia is a disorder characterized by the new onset of hypertension and proteinuria typically presenting after 20 weeks of gestation. Elevated circulating homocysteine is a risk factor for endothelial dysfunction and vascular diseases such as atherosclerosis and occlusive disorders. Our study is to investigate the association between elevated blood homocysteine levels and complications in pregnant women in order to conclude the clinical utility of homocysteine as a marker of severity in the cases of pre-eclampsia.

Conditions

  • Pre-Eclampsia
  • Critical Illness

Interventions

DIAGNOSTIC_TEST

homocysteine measurement

measuring the serum level of homocysteine

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-19
Primary Completion
2025-04-10
Completion
2025-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06413576 on ClinicalTrials.gov